ANGIOGENESIS
Scope & Guideline
Advancing Knowledge in Tumor Biology and Tissue Regeneration
Introduction
Aims and Scopes
- Molecular Mechanisms of Angiogenesis:
Research that elucidates the molecular pathways and signaling cascades involved in angiogenesis, including factors like VEGF, angiopoietins, and various growth factors. - Endothelial Cell Biology:
Studies focusing on endothelial cell function, plasticity, and interactions in health and disease, particularly in the context of vascular development and pathology. - Pathological Angiogenesis:
Exploration of abnormal angiogenesis in diseases such as cancer, diabetic retinopathy, and hereditary hemorrhagic telangiectasia, highlighting potential therapeutic targets. - Vascular Development and Regeneration:
Research on the processes of vasculogenesis and angiogenesis during development and tissue repair, including the role of stem cells and tissue engineering. - Clinical Applications and Therapeutics:
Studies that translate basic research findings into clinical applications, focusing on novel therapies for conditions associated with aberrant angiogenesis. - Inflammation and Angiogenesis:
Investigations into how inflammatory processes influence angiogenic responses, particularly in the context of chronic diseases and infections.
Trending and Emerging
- Angiogenesis in COVID-19 and Post-Viral Syndromes:
Research addressing the role of angiogenesis in COVID-19 and its long-term effects, including complications like post-COVID syndrome and microvascular dysfunction. - Mitochondrial Dysfunction and Angiogenesis:
An increasing number of studies are exploring the interplay between mitochondrial function and angiogenesis, particularly in pathological conditions such as diabetic retinopathy. - Utilization of iPSC-Derived Endothelial Cells:
The use of induced pluripotent stem cells (iPSCs) to study endothelial cell behavior and disease mechanisms is gaining momentum, providing insights into vascular development and regeneration. - Role of Extracellular Vesicles in Angiogenesis:
Emerging research on the role of extracellular vesicles and small RNAs in modulating angiogenic processes, particularly in cancer and inflammatory diseases. - Mechanobiology of Endothelial Cells:
A growing interest in how mechanical forces and the physical properties of the vascular microenvironment influence endothelial cell behavior and angiogenesis. - Targeted Therapeutics in Cancer Angiogenesis:
A trend towards the development of targeted therapies that specifically inhibit angiogenesis in tumor microenvironments, reflecting the need for precision medicine in oncology.
Declining or Waning
- Traditional Angiogenesis Models:
There has been a noticeable decrease in studies relying solely on classical in vitro angiogenesis assays, as newer technologies and models like organ-on-a-chip systems gain traction. - Generalized Anti-Angiogenic Therapies:
Research focusing on broad-spectrum anti-angiogenic therapies has waned, with a shift towards more targeted and personalized approaches in specific diseases. - Static Analysis of Endothelial Cells:
The focus on static, non-dynamic analyses of endothelial cells has declined, giving way to more dynamic studies that incorporate mechanical forces and cellular interactions. - Non-Specific Biomarker Studies:
There has been a reduction in publications centered on generic biomarkers for angiogenesis, as more specific and mechanistic approaches are favored. - Angiogenesis in Non-Pathological Contexts:
Less emphasis is placed on studying angiogenesis in normal physiological contexts, with a stronger focus on pathological conditions and their therapeutic implications.
Similar Journals
CELL BIOCHEMISTRY AND FUNCTION
Exploring the Intricacies of Biochemical FunctionalityCELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.
TISSUE & CELL
Unveiling the Mysteries of Cells and TissuesTISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Advancing Knowledge in Experimental PathologyINTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.
Journal of Biochemistry
Pioneering research in biochemistry and beyond.Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.
BIOCELL
Elevating Scientific Dialogue in Cell BiologyBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
GROWTH FACTORS
Advancing understanding of biological intricacies.GROWTH FACTORS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to advancing the field of cell biology, clinical biochemistry, and endocrinology. With an ISSN of 0897-7194 and an E-ISSN of 1029-2292, this journal has served as a vital platform for the dissemination of groundbreaking research since its inception in 1988. Although it operates without an Open Access model, GROWTH FACTORS focuses on providing high-quality, peer-reviewed articles that explore the intricate roles of growth factors in biological processes and their implications in health and disease. Holding a Q4 ranking in Cell Biology and Q3 rankings in Clinical Biochemistry and Endocrinology according to the 2023 category quartiles, the journal is well-regarded in its field and plays a crucial role in informing researchers, professionals, and students alike about the latest findings and innovations in these areas. The journal's commitment to fostering scientific dialogue ensures that it remains a key resource for those looking to enhance their understanding of growth factors and their applications in clinical settings.
Artery Research
Fostering collaboration to transform cardiovascular medicine.Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.
Cells & Development
Pioneering Research for a Deeper Understanding of LifeCells & Development is a premier journal published by Elsevier, dedicated to advancing the field of Developmental Biology. With an ISSN of 2667-2901 and an impressive Q2 ranking in its category for 2023, the journal endeavors to provide a platform for high-quality research articles that explore cellular mechanisms, developmental processes, and molecular interactions that underpin growth and differentiation. Based in the Netherlands, Cells & Development not only emphasizes the importance of innovative experimental approaches but also encourages interdisciplinary contributions that bridge the gap between basic and applied science. As an Open Access publication, it ensures that research findings are readily accessible to a global audience, significantly enhancing visibility and impact. The journal's commitment to scholarly excellence makes it an essential resource for researchers, professionals, and students aiming to contribute to the dynamic field of developmental biology.
DEVELOPMENTAL BIOLOGY
Exploring Cellular Journeys in DevelopmentDEVELOPMENTAL BIOLOGY, published by Academic Press Inc., Elsevier Science, stands as a pivotal journal in the fields of cell biology, developmental biology, and molecular biology since its inception in 1959. Renowned for its rigorous peer-review process, this journal serves as a platform for publishing cutting-edge research, reviews, and insights that drive forward our understanding of developmental processes at the cellular and molecular levels. With an impressive track record, it is classified in the Q2 quartile across multiple categories, reflecting its significant impact and relevance in academia and research communities. Although the journal does not provide Open Access options, it remains accessible via numerous academic databases, ensuring a wide reach for researchers, professionals, and students alike. With a commitment to advancing the field, DEVELOPMENTAL BIOLOGY continues to be essential reading for those looking to stay at the forefront of developmental research and its applications.
Inflammation and Regeneration
Connecting researchers to the latest in inflammation and regeneration.Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.